Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: <scp>CD45RA</scp> and <scp>CD371</scp> improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy

Abstract

Deep immunophenotypic analysis of the blast population is valuable for diagnosis of MDS and MDS/MPN and can potentially provide sensitivity and specificity figures comparable to those previously described using more comprehensive panels that assess maturing myelomonocytic and erythroid elements in addition to progenitor cells.